MEDTalks Leading the Future of Brain Metastases

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=De0I3CmCWKU

At#ESMO24 in Barcelona, MEDSIR held an insightful symposium titled MEDTalks: Leading the Future of Brain Metastases . • Moderated by Professor Antonio Llombart Cussac, MD PhD, Senior Scientific Leader at MEDSIR and Head of Medical Oncology at Arnau de Vilanova Hospital, and Professor Matthias Preusser, Head of the Oncology Division at the Medical University of Vienna and Chair of the EORTC Brain Tumor Group. This impactful event was sponsored by the Daiichi Sankyo | AstraZeneca alliance. • The symposium emphasized the crucial role of investigator-initiated trials as a key tool for advancing our understanding of brain metastases and developing innovative treatment strategies. These trials complement the breakthroughs achieved through industry-sponsored studies. • ✨ Event Highlights: • The indispensable contributions of investigator-initiated and industry-sponsored trials to shaping future treatment approaches. • Expert insights from renowned speakers, including Prof. Antonio Llombart-Cussac, Prof. Matthias Preusser, Prof. Manuel Valiente, Prof. Giuseppe Banna, Prof. Alfredo Addeo and Prof. Nathalie Albert. • Exploration of cutting-edge therapies, such as antibody-drug conjugates (ADCs), radioligands, and the promising future of theranostic oncology. • Stay ahead of the latest innovations in brain metastasis research! • #BrainMetastasis#CancerResearch#MedicalInnovation • 🇪🇸 En hashtag#ESMO24 en Barcelona, celebramos un simposio titulado MEDTalks: Liderando el Futuro de las Metástasis Cerebrales” • El simposio destacó el papel crucial de los ensayos clínicos iniciados por investigadores como una herramienta clave para avanzar en la comprensión de las metástasis cerebrales y desarrollar estrategias innovadoras de tratamiento. Estos ensayos complementan los avances logrados en los estudios patrocinados por la industria.

#############################

New on site